Inactivated polio vaccine and global polio eradication

The Lancet Infectious Diseases

Volumn 12, Issue 2, 2012, Pages 93-94

  Modlin, John F ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; POLIOMYELITIS VACCINE;

DIARRHEA; DIPHTHERIA; DISEASE CONTROL; IMMUNIZATION; IMMUNOGENICITY; LETTER; MUCOSAL IMMUNITY; NUTRITIONAL DEFICIENCY; OROPHARYNX; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; ROTAVIRUS; SANITATION; SEROPREVALENCE; TETANUS; WILD TYPE;

FEMALE; HUMANS; MALE; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL;

EID: 84856222461     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70312-7     Document Type: Letter

References (18)

1. Global eradication of poliomyelitis by the year 2000. Week Epidemiol Rec 1988, 63:161-162. WHO.
2. Patriarca PA, Wright PF, John TJ Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries. Rev Infect Dis 1991, 13:926-939.
3. Myaux JA, Unicomb L, Besser RE, et al. Effect of diarrhea on the humoral response to oral polio vaccination. Pediatr Infect Dis J 1996, 15:204-209.
4. Grassly NC, Fraser C, Wenger J, et al. New strategies for the elimination of polio from India. Science 2006, 314:1150-1153.
5. Caceres VM, Sutter RW Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. Clin Infect Dis 2001, 33:531-541.
6. Grassly NC, Wenger J, Durrani S, et al. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study. Lancet 2007, 369:1356-1362.
7. Wright PF, Modlin JF The demise and rebirth of polio-a modern phoenix?. J Infect Dis 2008, 197:335-336.
8. Estívariz CF, Jafari H, Sutter RW, et al. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial. Lancet Infect Dis 2011, published online Nov 8. 10.1016/S1473-3099(11)70190-6.
9. Krugman RD, Hardy GE, Sellers C Antibody persistence after primary immunization with trivalent oral poliovirus vaccine. Pediatrics 1977, 60:80-82.
10. Gelfand HM, LeBlanc DR, Potash L, Fox JP Studies on the development of natural immunity to poliomyelitis in Louisiana. IV. Natural infections with polioviruses following immunization with a formalin-inactivated vaccine. Am J Hyg 1959, 70:312-327.
11. Bijkerk H Poliomyeltis epidemic in the Netherlands. Dev Biol Stand 1979, 43:195-206.
12. Global Eradication Initiative Strategic Plan, 2004-2008 WHO, (accessed Dec 31, 2004). http://www.polioeradication.org/content/publications/2004stratplan.pdf.
13. Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries. Wkly Epidemiol Rec 2003, 78:241-250. WHO.
14. Asturias EJ, Dueger EL, Omer SB, et al. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants. J Infect Dis 2007, 196:692-698.
15. Kok PW, Leeuwenburg J, Tukei P, et al. Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population. Bull World Health Organ 1992, 70:93-103.
16. Mohammed AJ, AlAwaidy S, Bawikar S, et al. Fractional doses of inactivated poliovirus vaccine in Oman. N Engl J Med 2008, 362:2351-2359.
17. Simoes EA, John TJ The antibody response of seronegative infants to inactivated poliovirus vaccine of enhanced potency. J Biol Stand 1986, 14:127-131.
18. Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba. N Engl J Med 2007, 356:1536-1544. The Cuba IPV Study Collaborative Group.